About
Anindita Bose, PhD
Founder & Principal Consultant · Translational Neuroscience, Biomarkers & R&D Strategy
Anindita Bose, PhD, is a neuroscientist and life-sciences consultant specializing in translational neuroscience, neurodegenerative disease, biomarker and assay strategy, human iPSC disease models, and preclinical R&D planning.
She brings experience across academic medical centers and biotechnology organizations, including Harvard Medical School, Brigham and Women's Hospital, and Weill Cornell Medicine, with scientific expertise spanning Alzheimer's disease, Parkinson's disease, human neuronal models, and translational biomarker development.
Through NEURORAlife, she advises biotechnology companies, academic spinouts, and research organizations on translating scientific discoveries into rigorous experimental, biomarker, and development strategies.
Education & honors
- PhD, Neuroscience — Inserm / University of Paris 7
- MSc, Biotechnology — Bangalore University
- BSc (Hons), Zoology — Calcutta University
- Marie Curie Fellowship — Inserm / University of Paris 7
- Alzheimer's Drug Discovery Foundation Young Investigator Scholarship
- Parkinson's Action Network Award
- ICAD Fellowship
Record
Selected positions- 2024
Veravas
Senior Scientist, Biomarker Strategy & Assay Development
Led development and validation of translational biomarker assays (Tau ELISA, Aβ MSD), optimizing antibody reagent performance across sample matrices and building automated workflows that raised assay throughput.
- 2019–2024
Harvard Medical School · Brigham and Women's Hospital
Research Fellow / Research Scientist
Helped establish a new translational neuroscience laboratory — equipment, vendors, budget — and led in-vitro neuronal studies of a Parkinson's disease therapeutic, coordinating a multi-program translational portfolio with clinicians and industry partners.
- 2014–2018
Weill Cornell Medicine
Postdoctoral Associate
Built human iPSC-derived neuronal cultures for Parkinson's and Alzheimer's models; ran immunocytochemistry, high-content imaging, and quantitative image analysis; secured ESCRO approval for human cell studies and set lab-wide quality standards.
- 2010–2014
Karolinska Institute · Yale · Univ. of Minnesota · Roche
Research positions & internship
Quantitative analysis of Aβ-cleaving enzymes at Karolinska; electrophysiology in mouse slice cultures at Yale; manganese-toxicity Parkinson's models at Minnesota; a Roche internship developing quantitative ELISA systems for Alzheimer's biomarkers.
Publications
Full publication record available on PubMed.
Work with Anindita
Advisory engagements, program reviews, and hands-on assay and model strategy for teams moving neuroscience from bench to clinic.